Location

Please check the individual session for location or broadcast availability.  

Frequency

Monthly

Series Director

Frank Y. Lin, MD

Series Co-Director

Sarah Scollon, MS, CGC

Target Audience

Needs Statement

Healthcare providers in pediatric oncology require enhanced knowledge, competence, and performance capabilities to effectively utilize genomic data in clinical practice. They need a deeper understanding of advanced sequencing technologies, interpretation of molecular findings, and emerging trends and case-based insights in precision medicine using real-world examples. Clinicians must also develop the competence to critically evaluate molecular findings within a multidisciplinary framework, apply standardized variant classification systems, and integrate genomic insights into diagnostic and therapeutic decision-making. Additionally, learners need support in translating molecular findings into personalized treatment strategies, strengthening collaboration among multidisciplinary teams, and applying evidence-based approaches to improve patient outcomes in pediatric oncology. Through case-based discussions that encourage critical thinking and collaborative decision-making, this series aims to support changes in clinical practice by promoting the incorporation of relevant molecular findings into diagnostic and therapeutic strategies; encouraging collaboration among oncologists, pathologists, geneticists, and other specialists; and informing personalized, evidence-based treatment decisions when applicable to improve patient outcomes.

Educational Methods

Educational methods will include case presentations and panel discussion.

Objectives

At the conclusion of the sessions, the participants should be able to:

• Apply the results of tumor and germline molecular testing to the diagnosis, prognosis, and treatment of pediatric cancer.
• Demonstrate the expanding role of molecular diagnostics in formulating pediatric precision oncology treatment strategies.
• Integrate a multidisciplinary approach for interpreting results of molecular diagnostics.
• Evaluate the molecular tests currently available in pediatric oncology and recognize the limitations and risks of using them.

Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator